Antibodies to beta-interferons in multiple sclerosis - Can we neutralize the controversy?

被引：15

作者：

Cross, AH

Antel, JP

机构：

[1] Washington Univ, Sch Med, Dept Neurol & Neurosurg, Neuroimmunol Sect, St Louis, MO 63110 USA

[2] McGill Univ, Dept Neurol & Neurosurg, Neuroimmunol Unit, Montreal, PQ, Canada

来源：

NEUROLOGY | 1998年 / 50卷 / 05期

关键词：

D O I：

10.1212/WNL.50.5.1206

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1206 / 1208

页数：3

共 13 条

[1] INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

DUQUETTE, P ;

GIRARD, M ;

DESPAULT, L ;

DUBOIS, R ;

KNOBLER, RL ;

LUBLIN, FD ;

KELLEY, L ;

FRANCIS, GS ;

LAPIERRE, Y ;

ANTEL, J ;

FREEDMAN, M ;

HUM, S ;

GREENSTEIN, JI ;

MISHRA, B ;

MULDOON, J ;

WHITAKER, JN ;

EVANS, BK ;

LAYTON, B ;

SIBLEY, WA ;

LAGUNA, J ;

KRIKAWA, J ;

PATY, DW ;

OGER, JJ ;

KASTRUKOFF, LF ;

MOORE, GRW ;

HASHIMOTO, SA ;

MORRISON, W ;

NELSON, J ;

GOODIN, DS ;

MASSA, SM ;

GUTTERIDGE, E ;

ARNASON, BGW ;

NORONHA, A ;

REDER, AT ;

MARTIA, R ;

EBERS, GC ;

RICE, GPA ;

LESAUX, J ;

JOHNSON, KP ;

PANITCH, HS ;

BEVER, CT ;

CONWAY, K ;

WALLENBERG, JC ;

BEDELL, L ;

VANDENNOORT, S ;

WEINSHENKER, B ;

WEISS, W ;

REINGOLD, S ;

PACHNER, A ;

TAYLOR, W .

NEUROLOGY, 1993, 43 (04) :655-661

[2]

Duquette P, 1996, NEUROLOGY, V47, P889

[3]

FINKELMAN FD, 1993, J IMMUNOL, V151, P1235

[4] Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis [J].

Jacobs, LD ;

Cookfair, DL ;

Rudick, RA ;

Herndon, RM ;

Richert, JR ;

Salazar, AM ;

Fischer, JS ;

Goodkin, DE ;

Granger, CV ;

Simon, JH ;

Alam, JJ ;

Bartoszak, DM ;

Bourdette, DN ;

Braiman, J ;

Brownscheidle, CM ;

Coats, ME ;

Cohan, SL ;

Dougherty, DS ;

Kinkel, RP ;

Mass, MK ;

Munschauer, FE ;

Priore, RL ;

Pullicino, PM ;

Scherokman, BJ ;

WeinstockGuttman, B ;

Whitman, RH ;

Baird, WC ;

Fillmore, M ;

Bona, LM ;

ColonRuiz, ME ;

Nadine, BS ;

Donovan, A ;

Bennett, S ;

Kieffer, YM ;

Umhauer, MA ;

Miller, CE ;

Kilic, AK ;

Sargent, EL ;

Schachter, M ;

Shucard, DW ;

Weider, V ;

Catalano, BA ;

Cervi, JM ;

Czekay, C ;

Farrell, JL ;

Filippini, JS ;

Matyas, RC ;

Michienzi, KE ;

Ito, M ;

OMalley, JA .

ANNALS OF NEUROLOGY, 1996, 39 (03) :285-294

[5]

NESTAAS E, 1997, INTERFERON THERAPY M, P523

[6] QUANTITATION OF INTERFERON-INDUCED MX-PROTEIN IN WHOLE-BLOOD LYSATES BY AN IMMUNOCHEMILUMINESCENT ASSAY - ELIMINATION OF PROTEASE ACTIVITY OF CELL LYSATES IN-TOTO [J].

OH, SK ;

LUHOWSKYJ, S ;

WITT, P ;

RITCH, P ;

REITSMA, D ;

TOWBIN, H ;

HORISBERGER, M ;

VONWUSSOW, P ;

BLUESTEIN, B .

JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 176 (01) :79-91

[7] INFLUENCE OF INFECTION ON EXACERBATIONS OF MULTIPLE-SCLEROSIS [J].

PANITCH, HS .

ANNALS OF NEUROLOGY, 1994, 36 :S25-S28

[8] Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis [J].

Petkau, J ;

White, R .

MULTIPLE SCLEROSIS, 1997, 3 (06) :402-402

[9] In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis [J].

Philippe, J ;

Debruyne, J ;

LerouxRoels, G ;

Willems, A ;

Dereuck, J .

CLINICAL NEUROLOGY AND NEUROSURGERY, 1996, 98 (04) :286-290

[10] SENSITIVE ANTIPROLIFERATIVE NEUTRALIZATION ASSAY FOR THE DETECTION OF NEUTRALIZING IFN-ALPHA AND IFN-BETA ANTIBODIES [J].

PRUMMER, O ;

STREICHAN, U ;

HEIMPEL, H ;

PORZSOLT, F .

JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 171 (01) :45-53

← 1 2 →